Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-05-31T07:45:15.374Z Has data issue: false hasContentIssue false

Chapter 23 - Liver Disease in Immunodeficiencies in Children

from Section III - Hepatitis and Immune Disorders

Published online by Cambridge University Press:  19 January 2021

By
Nedim Hadžić
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Edited in association with
Jorge A. Bezerra ,
Cara L. Mack  and
Benjamin L. Shneider
Frederick J. Suchy
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Ronald J. Sokol
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
William F. Balistreri
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Jorge A. Bezerra
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Cara L. Mack
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Benjamin L. Shneider
Affiliation:
Texas Children’s Hospital, Houston
Get access

Summary

The liver plays an important role in the immune defense because of its central position adjacent to the gastrointestinal tract, representing the first line of defense against ingested or translocated pathogens and various antigens from diet.

Type
Chapter
Information
Liver Disease in Children , pp. 383 - 400
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mackay, IR. Hepatoimmunology: a perspective. Immunol Cell Biol 2002;80:36–44.CrossRefGoogle ScholarPubMed
Crispe, IN, Dao, T, Klugewitz, K, et al. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 2000;174:47–62.CrossRefGoogle ScholarPubMed
Weiler-Normann, C, Rehermann, B. The liver as an immunological organ. J Gastroenterol Hepatol 2004;19:S279–S283.Google Scholar
Rolando, N, Wade, J, Davalos, M, et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734–9.Google Scholar
Tilg, H, Wilmer, A, Vogel, W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–74.CrossRefGoogle ScholarPubMed
Izumi, S, Hughes, RD, Langley, PG, et al. Extent of the acute phase response in fulminant hepatic failure. Gut 1994;35:982–6.Google Scholar
Notarangelo, L. Primary immunodeficiencies. J Allergy Clin Immunol 2010;125:S182–S194.Google Scholar
Bousfiha, A, Jeddane, L, Picard, C, et al. The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies. J Clin Immunol 2018;38:129–43.Google Scholar
Hammer, SM. Management of newly diagnosed HIV infection. N Engl J Med 2005;353:1702–10.CrossRefGoogle ScholarPubMed
Davies, EG, Thrasher, AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol 2010;149:167–80.Google Scholar
Rodrigues, F, Davies, ED, Harrison, P, et al. Liver disease in primary immunodeficiencies. J Pediatr 2004;145:333–9.Google Scholar
Record, CO, Shilkin, KB, Eddleston, ALWF, Williams, R. Intrahepatic sclerosing cholangitis associated with a familial immunodeficiency syndrome. Lancet 1973;ii:18–20.CrossRefGoogle Scholar
Davis, JJ, Heyman, MB, Ferrell, L, et al. Sclerosing cholangitis associated with chronic cryptosporidiosis in a child with a congenital immunodeficiency disorder. Am J Gastroenterol 1987;82:1196–202.Google Scholar
Hayward, AR, Levy, J, Facchetti, F, et al. Cholangiopathy and tumours of the pancreas, liver and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 1997;158:977–83.CrossRefGoogle ScholarPubMed
McLauchlin, J, Amar, CFL, Pedraza-Diaz, S, et al. Polymerase chain reaction-based diagnosis of infection with Cryptosporidium in children with primary immunodeficiencies. Pediatr Inf Dis J 2003;22:329–34.Google Scholar
Stephens, J, Cosyns, M, Jones, M, Hayward, A. Liver and bile duct pathology following Cryptosporidium parvum infection of the immunodeficient mice. Hepatology 1999;30:27–35.Google Scholar
Chen, XM, Levine, SA, Tietz, P, et al. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology 1998;28:906–13.Google Scholar
Cello, JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989;86:539–46.Google Scholar
Gerber, DA, Green, M, Jaffe, R, Greenberg, D, et al. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000;4:50–5.Google Scholar
Hadzic, N, Pagliuca, A, Rela, M, et al. Correction of the hyper IgM-syndrome after liver and bone marrow transplantation.N Engl J Med 2000;342:320–4.CrossRefGoogle ScholarPubMed
Winkelstein, JA, Marino, MC, Ochs, H, et al. The X-linked hyper-IgM syndrome. Clinical and immunological features of 79 patients. Medicine 2003;82:373–84.CrossRefGoogle ScholarPubMed
Jain, A, Kovacs, JA, Nelson, DL, et al. Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand. Blood 2011;118:3811–17.Google Scholar
Martinez Ibanez, V, Espanol, T, Matamoros, N, et al. Relapse of sclerosing cholangitis after liver transplantation in patients with hyper-IgM syndrome. Transplant Proc 1997;29:432–3.Google Scholar
Thomas, C, De Saint, BG, Le Deist, F, et al. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation. N Engl J Med 1995;333:426–9.Google Scholar
Khawaja, K, Gennery, AR, Flood, TJ, et al. Bone marrow transplantation for CD40 ligand deficiency: a single centre experience. Arch Dis Child 2001;84:508–11.Google Scholar
Amrolia, P, Gaspar, HB, Hassan, A, et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000;96:1239–46.CrossRefGoogle ScholarPubMed
Jacobsohn, DA, Emerick, KM, Scholl, P, et al. Nonmyeloablative hematopoietic stem cell transplant for X-linked hyper-immunoglobulin M syndrome with cholangiopathy. Pediatrics 2004;113:122–7.Google Scholar
Kahn, K, Sharp, H, Hunter, D, Kerzner, B, et al. Primary sclerosing cholangitis in Wiskott–Aldrich syndrome. J Pediatr Gastroenterol Nutr 2001;32:95–9.Google Scholar
Blanshard, C, Shanson, DC, Gazzard, BG. Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of Cryptosporidiosis. Int J STD AIDS 1997;8:124–9.Google Scholar
Nachbaur, D, Kropshofer, G, Feichtinger, H, et al. Cryptosporidiosis after CD34- selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. Bone Marrow Transplant 1997;19:1261–3.Google Scholar
Rosignol, JF, Ayoub, A, Ayers, MS. Treatment of diarrhea caused by Cryptoporidium parvum: a prospective randomized, double-blind, placebo-controlled study of nitazoxanide. J Infect Dis 2001;184:103–6.Google Scholar
Gilger, MA, Gann, ME, Opekun, AR, Gleason, WA Jr. Efficacy of ursodeoxycholic acid in the treatment of primary sclerosing cholangitis in children. J Pediatr Gastroenterol Nutr 2000;31:136–41.Google Scholar
Bollinger, ME, Arredongo-Vega, FX, Santisteban, I, et al. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency. N Engl J Med 1996;334:1367–71.CrossRefGoogle ScholarPubMed
Bader-Meunier, B, Parez, N, Muller, S. Treatment of hemophagocytic lymphohistiocytosis with cyclosporin A and steroids in a boy with lysinuric protein intolerance. J Pediatr 2000;136:134.Google Scholar
Raby, RB, Ward, RB, Herrod, HG. Propionic academia and immunodeficiency. J Inherit Metab Dis 1994;17:250–1.CrossRefGoogle Scholar
Moreno, LA, Gottrand, F, Turck, D, et al. Severe combined immunodeficiency syndrome associated with autosomal recessive familial multiple gastrointestinal atresias: study of a family. Am J Med Genet 1990;37:143–6.Google Scholar
Gilroy, RK, Coccia, PF, Talmadge, JE, et al. Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. Blood 2004;103:1171–4.Google Scholar
Malamut, G, Ziol, M, Suarez, F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008;48:74–82.Google Scholar
Fiore, M, Ammendola, R, Gaetaniello, L, et al. Chronic unexplained liver disease in children with primary immunodeficiency syndromes. J Clin Gastroenterol 1998;26:187–92.CrossRefGoogle ScholarPubMed
Selik, RM, Lindegren, ML. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J 2003;22:635–641.Google Scholar
Fontana, M, Boldorini, R, Zuin, G, et al. Ultrastructural changes in duodenal mucosa of HIV-infected children J Pediatr Gastroenterol Nutr 1993;17:255–9.Google Scholar
Duffy, LF, Daum, F, Kahn, E, et al. Hepatitis in children with acquired immune deficiency syndrome: histopathologic and immunocytologic features. Gastroenterology 1986;90:173–81.CrossRefGoogle ScholarPubMed
Morotti, RA, Tata, M, Drut, R, et al. Liver pathology in children with AIDS: a comparison between the South American and North American population. Pediatr Pathol Mol Med 2001;20:537–45.Google Scholar
Lacaille, F, Fournet, JC, Blanche, S. Clinical utility of liver biopsy in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1999;18:143–7.CrossRefGoogle ScholarPubMed
Bouche, H, Housset, C, Dumont, JL, et al. AIDS-related cholangitis: diagnostic features and course in 15 patients.J Hepatol 1993;17:34–9.Google Scholar
Chung, CJ, Sivit, CJ, Rakusan, TA, et al. Hepatobiliary abnormalities on sonography in children with HIV infection. J Ultrasound Med 1994;13:205–10.Google Scholar
Clark, SJ, Creighton, S, Portmann, B, et al. Acute liver failure associated with antiretroviral treatment for HIV: a report of six cases. J Hepatol 2002;36:295–301.CrossRefGoogle ScholarPubMed
Church, JA, Mitchell, WG, Gonzales-Gomes, I, et al. Mitochondrial DNA depletion, near-fatal metabolic acidosis, and liver failure in an HIV-infected child treated with combination antiretroviral therapy. J Pediatr 2001;138:748–51.Google Scholar
Neff, GW, Bonham, A, Tzakis, AG, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transplant 2003;9:239–47.Google Scholar
Martin, P, DiBisceglie, AM, Kassianides, C, et al. Rapidly progressive non-A non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology 1989;97:1559–61.Google Scholar
Housset, C, Pol, S, Carnot, F, et al. Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus. Hepatology 1992;15:578–83.Google Scholar
Resti, M, Azzari, C, Bortolotti, F. Hepatitis C virus infection in children co-infected with HIV: epidemiology and management. Pediatr Drugs 2002;4:571–80.Google Scholar
Puoti, M, Torti, C, Bruno, R, et al. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006;44:S65–S70.Google Scholar
Benhamou, Y. Treatment algorithm for chronic hepatitis B in HIV-infected patients. J Hepatol 2006;44:S90–S94.Google Scholar
Lau, G, Suri, D, Liang, R, et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002;122:614–24.CrossRefGoogle ScholarPubMed
Quinti, I, Pandolfi, F, Paganelli, R, et al. HCV infection in patients with primary defects of immunoglobulin production. Clin Exp Immunol 1995;102:11–16.Google Scholar
Bjoro, K, Froland, SS, Yun, Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607–11.Google Scholar
Smith, MSH, Webster, DB, Dhillon, AP, et al. Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 1995;108:879–84.Google Scholar
Gow, PJ, Mutimer, D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transplant Int 2002;15:380–383.Google Scholar
Filipovich, AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin N Am 2008;28:293–313.Google Scholar
Freeman, HR, Ramanan, AV. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child 2011;96:688–93.Google Scholar
Hirst, WJ, Layton, DM, Singh, S, et al. Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. BrJ Haematol 1994;88:731–9.Google Scholar
Henter, JI, Horne, A, Arico, M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124–31.Google Scholar
Farquhar, JW, Claireaux, AE. Familial haemophagocytic reticulosis. Arch Dis Child 1952;27:519–25.Google Scholar
Arico, M, Danesino, C, Pende, D, Moretta, L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114:761–9.Google Scholar
Chisuwa, H, Hashikura, Y, Nakazawa, Y, et al. Fatal hemophagocytic syndrome after living-related liver transplantation: a report of two cases. Transplantation 2001;72:1843–6.Google Scholar
Ohadi, M, Lalloz, MR, Sham, P, et al. Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3–22 by homozygosity mapping. Am J Hum Genet 1999;64:165–71.Google Scholar
Dufourcq-Lagelouse, R, Jabado, N, Le Deist, F, et al. Linkage of familial hemophagocytic lymphohistiocytosis to 10q21–22 and evidence for heterogeneity. Am J Hum Genet 1999;64:172–9.Google Scholar
Feldmann, J, Callebaut, I, Raposo, G, et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 2003;115:461–73.Google Scholar
zur Stadt, U, Schmidt, S, Kasper, B, et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Gen 2005;14:827–34.Google Scholar
Côte, M, Ménager, MM, Burgess, A, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest 2009;119:3765–73.Google Scholar
Kogawa, K, Lee, SM, Villanueva, J, et al. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61–6.Google Scholar
Clementi, R, Locatelli, F, Dupre, L, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 2005;105:4424–8.Google Scholar
Stephan, JL, Donadieu, J, Ledeist, F, et al. Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood 1993;82:2319–23.Google Scholar
Fischer, A, Cerf-Bensussan, N, Blanche, S, et al. Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. J Pediatr 1986;108:267–70.Google Scholar
Durken, M, Horstmann, M, Bieling, P, et al. Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients. Br J Haematol 1999;106:1052–8.Google Scholar
Cooper, N, Rao, K, Gilmour, K, et al. Stem cell transplantation with reduced intensity conditioning for haemophagocytic lymphohistiocytosis. Blood 2006;107:1233–6.Google Scholar
Matthes-Martin, S, Peters, C, Koningsrainer, A, et al. Successful stem cell transplantation following liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000;96:3997–9.Google Scholar
Purtilo, DT, Cassel, CK, Yang, JPS, et al. X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease). Lancet 1975;i:935–41.Google Scholar
Howie, D, Sayos, J, Terhorst, C, Morra, M. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein–Barr virus. Curr Opin Immunol 2000;12:474–8.Google Scholar
Nichols, KE, Ma, CS, Cannons, JL, et al. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol Rev 2005;203:180–99.Google Scholar
Sayos, J, Wu, C, Morra, M, et al. The X linked lymphoproliferative: disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998;395:462–9.CrossRefGoogle ScholarPubMed
Skare, JC, Sullivan, JL, Milunsky, A. Mapping the mutation causing the X- linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq. Hum Genet 1989;82:349–53.CrossRefGoogle ScholarPubMed
Rigaud, S, Fondaneche, MC, Lambert, N, et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006;444:110–14.Google Scholar
Paclopnik Schmid, J, Canioni, D, Moshous, D, et al. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 2011;117:1522–9.Google Scholar
Milone, MC, Tsai, DE, Hodinka, RL, et al. Treatment of primary Epstein–Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell- directed therapy. Blood 2005;105:994–6.Google Scholar
Finn, A, Hadzic, N, Morgan, G, Strobel, S, Levinsky, RJ. Prognosis of chronic granulomatous disease. Arch Dis Child 1990;65:942–5.Google Scholar
Muorah, M, Hinds, R, Verma, A, et al. Liver abscesses in children in the developed world: a single centre experience. J Pediatr Gastroenterol Nutr 2006;42:201–6.CrossRefGoogle Scholar
Yonkof, JR, Gupta, A, Fu, P, Garabedian, E, Dalal, J; and the United States Immunodeficiency Network Consortium. Role of Allogeneic Hematopoietic Stem Cell Transplant for Chronic Granulomatous Disease (CGD): a Report of the United States Immunodeficiency Network. J Clin Immunol 2019;39:448–58.Google Scholar
Rand, EB, Karpen, SJ, Kelly, S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155:566–71.Google Scholar
Tung, J, Hadzic, N, Layton, M, et al. Bone marrow failure in children with acute liver failure. J Pediatr Gastroenterology Nutr 2000;31:557–61.Google Scholar
Maggiore, G, Sciveres, M, Fabre, M, et al. Giant cell hepatitis with autoimmune hemolytic anemia in early childhood: long-term outcome in 16 children.J Pediatr 2011;159:127–32.Google Scholar
Whitington, PF, Kelly, S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008;121:e1615–e1621.Google Scholar
INIS Collaborative Group. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011;365:1201–11.Google Scholar
Bucuvalas, JC, Anand, R. Studies of the Pediatric Liver Transplantation Research Group. Treatment with immunoglobulin improves outcome for pediatric liver transplant recipients. Liver Transplant 2009;15:1564–9.Google Scholar
Krischock, L, Marks, SD. Induction therapy: why, when, and which agent? Pediatr Transplant 2010;14:298–313.Google Scholar
Soliman, T, Hetz, H, Burghuber, C, et al. Short-term induction therapy with anti- thymocyte globulin and delayed use of calcineurin inhibitors in orthotopic liver transplantation. Liver Transplant 2007;13:1039–44.Google Scholar
Kerkar, N, Morotti, RA, Iyer, K, et al. Anti-lymphocyte therapy successfully controls late “cholestatic” rejection in pediatric liver transplant recipients. Clin Transplant 2011;25:E584–E591.Google Scholar
Hadzić, N, Height, S, Ball, S, et al. Evolution in the management of acute liver failure-associated aplastic anaemia in children: a single centre experience. J Hepatol 2008;48:68–73.Google Scholar
Norin, S, Kimby, E, Ericzon, BG, et al. Posttransplant lymphoma: a single-center experience of 500 liver transplantations. Med Oncol 2004;21:273–84.Google Scholar
Hale, DA. Biological effects of induction immunosuppression. Curr Opin Immunol 2004;16:565–70.Google Scholar
Spada, M, Petz, W, Bertani, A, et al. Randomized trial of basiliximab induction versus steroid therapy in ediatric liver allograft recipients under tacrolimus immunosuppression.Am J Transplant 2006;6:1913–21.Google Scholar
Rovelli, A, Corti, P, Beretta, C, et al. Alemtuzumab for giant cell hepatitis with autoimmune hemolytic anemia. J Pediatr Gastroenterol Nutr 2007;45:596–9.Google Scholar
Schub, N, Günther, A, Schrauder, A, et al. Therapy of steroid-refractory acute GVHD with CD52 antibody alemtuzumab is effective. Bone Marrow Transplant 2011;46:143–7.Google Scholar
Gutierrez-Aguirre, CH, Cantu’-Rodriguez, OG, Borjas-Almaguer, OD, et al. Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease. Haematologica 2012;97:717–22.Google Scholar
Kato, T, Selvaggi, G, Panagiotis, T, et al. Pediatric liver transplant with campath 1 H induction: preliminary report. Transplant Proc 2006;38:3609–11.Google Scholar
Levitsky, J, Thudi, K, Ison, MG, et al. Alemtuzumab induction in non-hepatitis C positive liver transplant recipients. Liver Transplant 2011;17:32–7.Google Scholar
Taylor, RP, Lindorfer, MA. Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies. Curr Opin Immunol 2008;20:444–9.Google Scholar
Cooper, N, Arnold, DM. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol 2010;149:3–13.Google Scholar
Gobert, D, Bussel, JB, Cunningham-Rundles, C, et al. Efficacy and safety of rituximab in common variable immunodeficiency-associated immune cytopenias: a retrospective multicentre study on 33 patients. Br J Haematol 2011;155:498–508.Google Scholar
Messahel, B, Taj, MM, Hobson, R, et al. Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children’s Cancer Study Group (UKCCSG) retrospective review. Leuk Lymphoma 2006;47:2584–9.Google Scholar
Miloh, T, Manwani, D, Morotti, R, et al. Giant cell hepatitis and autoimmune hemolytic anemia successfully treated with rituximab. J Pediatr Gastroenterol Nutr 2007;44:634–6.Google Scholar
Czubkowski, P, Williams, M, Bagia, S, Kelly, D, Gupte, G. Immune-mediated hemolytic anemia in children after liver and small bowel transplantation. Liver Transplant 2011;17:921–4.Google Scholar
Shores, D, Kobak, G, Pegram, LD, Whitington, PF, Shneider, BL. Giant cell hepatitis and immune thrombocytopenic purpura: reversal of liver failure with rituximab therapy. J Pediatr Gastroenterol Nutr 2012;55(4):e128–e130.Google Scholar
Miloh, T, Arnon, R, Roman, E, et al. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature. Pediatr Transplant 2011;15:870–8.Google Scholar
Siebold, L, Dick, AA, Thompson, R, et al. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease). Liver Transplant 2010;16:856–63.Google Scholar
Tsuda, M, Moritoki, Y, Lian, ZX, et al. Biochemical and immunologic effects of rituximab in primary biliary cirrhosis patients with an incomplete response to ursodeoxycholic acid. Hepatology 2012;55:512–21.Google Scholar
Wolach, O, Shpilberg, O, Lahav, M. Neutropenia after rituximab treatment: new insights on a late complication. Curr Opin Hematol 2012;19(1):32–8.Google Scholar
Cambridge, G, Leandro, MJ, Teodorescu, M, et al. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles. Arthritis Rheum 2006;54:3612–22.Google Scholar
Kolstad, A, Holte, H, Fossa, A, Lauritzsen, GF, Gaustad, P, Torfoss, D. Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica 2007;92:139–40.Google Scholar
Green, M, Michaels, MG, Katz, BZ, et al. CMV-IVIG for prevention of Epstein–Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 2006;6:1906–12.Google Scholar
Patterson, SJ, Angus, PW. Post-liver transplant hepatitis B prophylaxis: the role of oral nucleos(t)ide analogues. Curr Opin Organ Transplant 2009;14:225–30.Google Scholar
Grunebaum, E, Avitzur, Y. Liver-associated immune abnormalities. Autoimmun Rev 2019;18:15–20.Google Scholar
Shah, T, Cale, C, Hadzic, N, Jones, A. Dedicator of cytokinesis 8 deficiency: a predisposition to sclerosing cholangitis. Clin Immunol 2014;155: 71–3.Google Scholar
Yazdani, R, Fekrvand, S, Shahkarami, S, et al.The hyper IgM syndromes: epidemiology, pathogenesis, clinical manifestations, diagnosis and management. Clin Immunol 2019;198:19–30.Google Scholar
de la Morena, MT, Leonard, D, Torgerson, TR, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol 2017;139:1282–92.CrossRefGoogle ScholarPubMed
Azzu, V, Kennard, L, Morillo-Gutierrez, B, et al. Liver disease predicts mortality in patients with X-linked immunodeficiency with hyper-IgM but can be prevented by early hematopoietic stem cell transplantation. J Allergy Clin Immunol 2018;141:405–8.e7.Google Scholar
Barbouche, MR, Chen, Q, Carbone, M, et al. Comprehensive review of autoantibodies in patients with hyper-IgM syndrome. Cell Mol Immunol 2018;15:610–17.Google Scholar
Quarello, P, Tandoi, F, Carraro, F, et al. Successful sequential liver and hematopoietic stem cell transplantation in a child with CD40 ligand deficiency and cryptosporidium-induced liver cirrhosis. Transplantation 2018;102:823–8.Google Scholar
Hadzic, N. Is nodular regenerative hyperplasia an immune-mediated phenomenon ? Hepatology 2019;69(6):2717–18.Google Scholar
Bucciol, G, Nicholas, SK, Calvo, PL, et al. Combined liver and hematopoietic stem cell transplantation in patients with X-linked hyper-IgM syndrome. J Allergy Clin Immunol 2019;143:1952–6.e6.Google Scholar
Chavez, MA, White, AC Jr. Novel treatment strategies and drugs in development for cryptosporidiosis. Expert Rev Anti Infect Ther 2018;16:655–61.Google Scholar
Hartleif, S, Lang, P, Handgretinger, R, et al. Outcomes of pediatric identical living-donor liver and hematopoietic stem cell transplantation. Pediatr Transplant 2016;20(7):888–97.Google Scholar
Fischler, B, Baumann, U, Dezsofi, A, et al.Hepatitis E in Children: A Position Paper by the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2016;63(2):288–94.Google Scholar
Westhölter, D, Hiller, J, Denzer, U, et al.HEV-positive blood donations represent a relevant infection risk for immunosuppressed recipients. J Hepatol 2018;69(1):36–42.Google Scholar
Acharya, C, Dharel, N, Sterling, RK. Chronic liver disease in the human immunodeficiency virus patient. Clin Liver Dis 2015;19(1):1–22.Google Scholar
Blumberg, EA, Rogers, CC. Solid organ transplantation in the HIV-infected patient: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;17:e13499.Google Scholar
Rowley, MW, Patel, A, Zhou, W, Wong, M, Seetharam, AB. Immune reconstitution syndrome with initiation of treatment of HBV/HIV co-infection: activity flare associated with E antigen seroconversion. Ann Hepatol 2019;18(1):220–4.CrossRefGoogle ScholarPubMed
Sikavi, C, Chen, PH, Lee, AD, Saab, EG, Choi, G, Saab, S. Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: no longer a difficult-to-treat population. Hepatology 2018;67(3):847–57.CrossRefGoogle ScholarPubMed
Saxena, V, Khungar, V, Verna, EC, et al. Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: results from the HCV-TARGET study. Hepatology 2017;66(4):1090–101Google Scholar
Minoia, F, Bovis, F, Davì, S, et al. Development and initial validation of the macrophage activation syndrome/primary hemophagocytic lymphohistiocytosis score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome. J Pediatr 2017;189:72–8.e3.Google Scholar
Wozniak, LJ, Naini, BV, Hickey, MJ, et al. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature. Pediatr Transplant 2017;21(1):e12869.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×